title: Risk factors associated with extended spectrum beta-lactamase Escherichia coli (CTX-M) on dairy farms in North West England and North Wales.
abstract: This study investigated the potential spread of CTX-M-14 Escherichia coli from a known ESBL E. coli positive farm and risk factors for the presence of CTX-M E. coli on dairy farms. Between November 2009 and March 2010, 65 farms in North West England and North Wales were visited and animals sampled for E. coli producing CTX-M ESBLs. Seventeen of these were known to have received animals from a known ESBL E. coli positive 'index' farm since 2005 (linked farms). The prevalence of CTX-M E. coli in the population of linked farms was 58.8% (10/17; CI(95%) 32.9-81.6%) and in the randomly selected control population was 35.4% (17/48; CI(95%) 22.2-50.5%). There was no significant (p>0.05) linkage for the detection of any CTX-M E. coli or specifically a CTX-M-14 E. coli to the index farm. Group 1 (CTX-M-15, CTX-M-55, CTX-M-1, CTX-M-32), group 2 (CTX-M-2) and group 9 (CTX-M-14, CTX-M-14 B, CTX-M-27) CTX-M E. coli were identified on the study farms. Molecular analysis revealed that three plasmids from linked farms had similar sizes (95 kbp), replicon type (IncK) and backbone genes as that from the index farm. Logistic regression analysis revealed that farms that had used a 3rd or 4th generation cephalosporin (ceftiofur, cefoperazone and cefquinome) in livestock in the last 12 months were nearly 4 times more likely to have ESBL E. coli present (p=0.037; OR=3.93). There was no significant association between presence of CTX-M E. coli and the use of any 1st or 2nd generation cephalosporins. Several other risk factors for the presence of CTX-M E. coli were identified, such as storage of slurry in a pit, operating an open herd policy and infrequent cleaning of calf feeding equipment.
authors.affiliation: Animal Health and Veterinary Laboratories Agency - Centre for Epidemiology and Risk Analysis, New Haw, Addlestone, Surrey KT15 3NB, United Kingdom.
authors.forename: L C
authors.initials: LC
authors.lastname: Snow
authors.forename: R G
authors.initials: RG
authors.lastname: Warner
authors.forename: T
authors.initials: T
authors.lastname: Cheney
authors.forename: H
authors.initials: H
authors.lastname: Wearing
authors.forename: M
authors.initials: M
authors.lastname: Stokes
authors.forename: K
authors.initials: K
authors.lastname: Harris
authors.forename: C J
authors.initials: CJ
authors.lastname: Teale
authors.forename: N G
authors.initials: NG
authors.lastname: Coldham
mesh_terms: D000818:Animals; D002417:Cattle; D002418:Cattle Diseases / Q000453:epidemiology* / Q000382:microbiology; D002511:Cephalosporins / Q000009:adverse effects / Q000627:therapeutic use; D004269:DNA, Bacterial / Q000032:analysis; D004739:England / Q000453:epidemiology; D004926:Escherichia coli / Q000201:enzymology* / Q000302:isolation & purification; D004927:Escherichia coli Infections / Q000453:epidemiology / Q000382:microbiology / Q000662:veterinary*; D005260:Female; D016015:Logistic Models; D010957:Plasmids / Q000235:genetics; D015995:Prevalence; D012307:Risk Factors; D014852:Wales / Q000453:epidemiology; D001618:beta-Lactamases / Q000235:genetics
chemical_list: D002511:Cephalosporins; D004269:DNA, Bacterial; C456080:beta-lactamase CTX-M-14; D001618:beta-Lactamases